medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2019, Number S1

<< Back Next >>

Acta Med 2019; 17 (S1)

Preservation of fertility

Kably AA, Sánchez AA

Language: Spanish
References: 20
Page: 67-71
PDF size: 127.17 Kb.


ABSTRACT

Age, genomic syndromes and treatments that result in gonadal toxicity can affect reproductive capability. Fertility preservation is an option for reproductive age population, depending on the pathology and social environment. In the last decade, fertility preservation has been increasing due to oncological and non-oncological reasons, meeting the demand will be a challenge in the future. A timely reference to a specialist is becoming essential. Currently, several techniques with high success rates had been established.


REFERENCES

  1. Martinez F, International Society for Fertility Preservation ESHRE-ASRM Expert Working Group. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: Indications, results and future perspectives. Fertil Steril. 2017; 108 (3): 407-415.

  2. Kohler H, Billari F, Ortega J. The emergence of lowest low fertility in Europe during the 1990s. Popul Dev Rev. 2002; 28 (4): 641-660.

  3. Goldstein JR, Sobotka T, Jasilioniene A. The end of lowest-low fertility? Popul Dev Rev. 2009; 35 (4): 663-700.

  4. Ethics Committee of ASRM. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013; 100 (5): 1224-1231.

  5. Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017; 377 (17): 1657-1665.

  6. Hodes-Wertz B, Druckenmiller S Smith, M Noyes N. What do reproductive-age women who undergo oocyte cryopreservation think about the process as a means to preserve fertility? Fertil. Steril. 2013; 100 (5): 1343-1349.

  7. Mills M, Rindfuss RR, McDonald P, te Velde E, ESHRE Reproduction and Society Task Force. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update. 2011; 17 (6): 848-860.

  8. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: Final data for 2017. Natl Vital Stat Rep. 2018; 67 (8): 1-55.

  9. Speroff L, Fritz M. Técnicas de reproducción asistida en endocrinología ginecológica clínica y esterilidad. 8a. ed Madrid. Lippincott Williams & Wilkins. 2015. pp: 1215-1274.

  10. Soriano KP, Carballo E, Roque AM, Durán L, Kably A. Percepción de fertilidad de mujeres en edad reproductiva de acuerdo a su edad. Ginecol Obstet Mex. 2017; 85 (6): 364-373.

  11. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013; 31 (19): 2500-2510.

  12. ISFP Practice Committee, Kim SS, Donnez J, Barri P, Pellicer A, Patrizio P et al. Recommendations for fertility preservation in patients with lym phoma, leukemia, and breast cancer. J Assist Reprod Genet. 2012; 29 (6): 465-468.

  13. Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced age: a committee opinion. Fertil Steril. 2013; 100 (2): 337-340.

  14. Donnez J, Dolmans MM. Fertility preservation in women. Nat Rev Endocrinol. 2013; 9 (12): 735-749.

  15. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Practice Committee of the American Society for Reproductive Medicine. Female age-related fertility decline. Committee Opinion No. 589. Obstet Gynecol. 2014; 123 (3): 719-721.

  16. Gook DA. History of oocyte cryopreservation. Reprod Biomed Online. 2011; 23 (3): 281-289.

  17. Ethics Committee of the American Society for Reproductive Medicine. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion. Fertil Steril. 2018; 110 (6): 1022-1028.

  18. Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016; 105 (3): 755-764.

  19. Donnez J, Dolmans MM, Diaz C, Pellicer A. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil Steril. 2015; 104 (5) 1097-1098.

  20. Diaz-Garcia C, Domingo J, Garcia-Vellasco JA, Herraiz S, Mirabet V, Iniesta I et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018; 109 (3): 478-485.




2020     |     www.medigraphic.com